Dear Forum Members,
We wish to inform you that, following careful consideration, we have taken the decision to discontinue and close the discussion forum on 31 January 2025.
Please rest assured that our team remains available to assist with any questions or concerns via our contact form. We sincerely appreciate the opportunity to have served you, and we thank you for your understanding and continued trust.
Thank you again for being an integral part of our community!
Yours sincerely,
EPO
Important Announcement: Closure of the Discussion Forum on 31 January 2025
-
Patent_Knowledge@EPO
- Posts: 26
- Joined: Thu May 23, 2024 2:36 pm
-
gerben
- Posts: 52
- Joined: Tue Feb 27, 2007 10:29 am
- Location: Nijmegen, The Netherlands
Re: Important Announcement: Closure of the Discussion Forum on 31 January 2025
Sorry to hear of this decision,
The forum was a useful tool, in case you ran into your in-house code not behaving as expected. Frequently, someone had run into the same or similar issue before and a solution, or an explanation why this was unavoidable because of data (un)availability or its organisation in OPS, was commonly present under the question.
In my opinion the forum was also a time saver for EPO staff. Questions answered by other forum users did not need further attention (and time) of EPO staff, which the suggested alternative, sending messages to the EPO staff via the contact form will always need.
I do not know if "careful consideration" did include the above arguments, if not, please re-consider.
Regards,
Gerben
The forum was a useful tool, in case you ran into your in-house code not behaving as expected. Frequently, someone had run into the same or similar issue before and a solution, or an explanation why this was unavoidable because of data (un)availability or its organisation in OPS, was commonly present under the question.
In my opinion the forum was also a time saver for EPO staff. Questions answered by other forum users did not need further attention (and time) of EPO staff, which the suggested alternative, sending messages to the EPO staff via the contact form will always need.
I do not know if "careful consideration" did include the above arguments, if not, please re-consider.
Regards,
Gerben